Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Hangzhou Sumgen Biotech Co., Ltd.

Clinical trials sponsored by Hangzhou Sumgen Biotech Co., Ltd., explained in plain language.

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 3

New lupus shot shows promise in Mid-Stage trial

Disease control Recruiting now

This study tests a new medicine called SG301, given as an injection under the skin, for people with systemic lupus erythematosus (SLE). The goal is to see if it can reduce lupus disease activity better than a placebo. About 120 adults with active lupus who haven't responded well …

Phase: PHASE2 • Sponsor: Hangzhou Sumgen Biotech Co., Ltd. • Aim: Disease control

Last updated May 20, 2026 11:55 UTC